Skip to content
Sign in
Venture capitalBacked 1 network startup

SOSV

Self-described most active pre-seed deep-tech investor, backing human and planetary health from pre-seed through follow-on rounds.

Princeton, United States sosv.com LinkedIn
Ticket
Up to $550K
Assets under management
—
Founded
—
Stages
Pre-seedto Series A
Network startups backed
1
Co-investors
1most often with Five35 Ventures

How they invest

Deep-tech companies in human and planetary health: biotech, climate, materials, robotics and healthtech, often via its accelerator programmes. Portfolio (NotCo, Upside Foods, Opentrons, Novoloop, Smartex, RxAll, ZymoChem) shows synthetic bio, materials and lab tools.

Stage and ticket

Pre-seed to Series A; first cheques up to ~$0.55M, with follow-ons.

Geography

Global (US, Europe, Asia).

Thesis

Backs deep tech companies working on human and planetary health from pre-seed through follow-on rounds.

What makes them say yes

  • Hard science with defensible IP
  • Clear human or planetary health impact
  • Lab-to-market plan within accelerator timelines

Red flags

  • Software-only companies without deep tech
  • Late-stage companies

Sectors

  • Deep tech & materials
  • Biotech & life sciences
  • Climate & energy
  • Robotics & hardware
  • HealthTech

Stages

  • Pre-seed
  • Seed
  • Series A

Geographies

  • Global
  • United States
  • Europe
  • Asia

How to approach

ZymoChem (SOSV pre-seed, later Toyota Ventures and DOE-backed) is the warm path. Apply to SOSV's accelerator programmes for bio and hardware.

Portfolio

1 network startup · 6 other companies

Synthetic biology, alternative proteins, materials and lab tools; ZymoChem is the network holding.

Gaps in the portfolio

  • Biopesticides
  • Ingestible diagnostics
  • Bioenergy crops

Network startups

  • ZymoChem2026 World Champion

    Carbon-efficient microbial fermentation platform producing BAYSE, a bio-based superabsorbent designed to replace petroleum SAP in hygiene products.

    United States · Biotech & life sciences

Other portfolio companies

From the investor's own sources. These companies are not on the network yet.

  • NotCo
  • Novoloop
  • Opentrons
  • RxAll
  • Smartex
  • Upside Foods

Network startups that fit

5 analysed

Davis biotech using baker’s yeast to deliver RNAi that kills insect pests, starting with cockroaches, without hazardous chemicals.

Yeast-delivered RNAi biopesticides, founded 2025: synthetic biology for planetary health at the earliest stage, SOSV's core pattern.

55%confidence

Evidence from the records

  • “Yeast-based RNAi biopesticides”
  • “RNAi biopesticide platform in development”
Intro path
ZymoChem founders (SOSV portfolio).
First step
Apply to SOSV's bio accelerator.

Tufts spin-off with an IRB-approved ingestible capsule that samples small-intestine microbiome and contents non-invasively.

Tufts ingestible gut-sampling capsule with IRB approval: human-health deep tech hardware at pre-seed.

45%confidence

Evidence from the records

  • “Ingestible small intestine sampling capsule”
  • “Capsule validated in 3 large animal models”
First step
Pitch with the first-in-human plan.

Drop-in thermostable microbial additive that makes compostable plastics fully degrade, sold to processors facing rising EPR fees.

Microbial additive making compostable plastics degrade fully: materials biotech like Novoloop/ZymoChem.

45%confidence

Evidence from the records

  • “Biodegradable plastics / microbial additives”
  • “Additive at TRL 5 in commercial-scale pilot tests”
Intro path
SeaAhead and MassCEC (EvoNatura investors).
First step
Share pilot results with SOSV.

St. Louis start-up breeding dwarf bioenergy sorghum grown between corn rows to give farmers biomass income for power plants.

Symbiotic bioenergy crops from St. Louis, Arch Grants winner: plant biotech for planetary health.

40%confidence

Evidence from the records

  • “Plant breeding for bioenergy crops”
  • “Arch Grants 2026 winner”
Intro path
Arch Grants (Amass investor).
First step
Pitch once first pilots are booked.

Lab-stage electrochemical route to ammonia at room temperature from air and water, targeting distributed, low-carbon nitrogen fertiliser.

Room-temperature ammonia from air and water: climate deep tech, lab-stage with no pilot yet.

30%confidence

Evidence from the records

  • “Green ammonia / fertilizer decarbonization”
  • “lab technology published in ACS Energy Letters”
First step
Revisit after the Chicago pilot is funded.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Five35 Ventures

Sources

  1. 1sosv.com/

Profile compiled from public sources. Unknown fields are left empty rather than estimated.